CIDRAP newsletters options
Two measles patients this week, a child from New Mexico and an adult from Minnesota, contracted the virus on domestic flights.
The findings underscore the need for continued surveillance to monitor the long-term dynamics of SARS-CoV-2 in deer and the related zoonotic risks.
Sequencing linked the cases to an older H5N1 clade still circulating in India and Bangladesh.
The findings suggest that many signs and symptoms may improve with time.
Of the 2,066 counties, 1,614 (78%) showed a decline in coverage of the measles, mumps, and rubella vaccine.
In other developments, states with links to the large West Texas outbreak reported a few more cases today.
More than 3 years after they received twice-yearly doses of azithromycin or placebo in a randomized trial, children in Malawi had elevated levels of macrolide-resistant Streptococcus pneumoniae.
In the past, CDC vaccine use recommendations were based on a thorough, public review of relevant evidence.
Beneficiaries with 4 or more COVID-19 vaccine doses had a 39% lower rate of long COVID.
Since the middle of May, 3 Arizona outbreaks have led to the loss of more than 5 million layer poultry.
Data from 11 Wellcome-funded research projects show that the relationship between vaccination and its impact on AMR is "rarely straightforward."
In total, 55% of active tuberculosis, 99% of latent tuberculosis, 61% of hepatitis B, 35% of HIV, and 83% of hepatitis C infections were new diagnoses.
The cases were detected in white-tailed deer in the Panhandle Region of northern Idaho.
Other states report more cases, including Minnesota, with two, one of which involves a child whose infection suggests community spread.
Nearly 1,000 final progress reports (less than 1% of awards made from 2014 through 2024) were delinquent.
Vaccines averted the highest rate of deaths during the Delta period, with 68% of deaths averted.
The US has been hit hardest, with more than 10,000 cases and 5 deaths, 4 of them in children younger than 1 year.
Among 45 cases, 16 people have required hospitalization.
The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk of severe disease.
A retrospective analysis of hospitalized VA patients finds that prior flu or RSV infection more than doubled the odds of subsequent Streptococcus pneumoniae infection.
